I have followed this stock for a long time and I have never seen more reason for optimism.
Here's a few of the recent indicators:
- Aug 11, 2023 - Biosenta releases news about a Solution fighting a drug-resistant fungus in hospitals of US and Canada
https://www.biosenta.com/post/solution-fighting-a-drug-resistant-fungus-in-hospitals-of-usa-and-canada
- also Aug 11, 2023 - insider reports show the CEO, Am Gill, buying shares
- Sep 6, 2023 Biosenta announces partnership with AMPAK to test and commercialize TriFiller
https://www.biosenta.com/post/biosenta-builds-on-partnership-with-ampak-to-test-and-commercialize-tri-filler
- Sep 28, 2023 Biosenta announces breakthrough discovery in anti-microbial efficacy of Tri-Filler
https://www.biosenta.com/post/biosenta-announces-breakthrough-discovery-in-anti-microbial-efficacy-of-tri-filler
So, not only are the scientific results being proven up, the organization has also entered into commercial agreements with real players in the market.
I gather there was a recent AGM where management expressed plenty of optimism. I know there have been detractors of this company on this board. If you are still bearish enough on this company to post here, I will assume you attended the AGM and addressed your concerns to management directly? What were their responses?
Failing any reasonable data to the contrary, I am extremely bullish about this one. Its nice to say that after a long, long road with Biosenta.
I can't wait to see what is next. I think its worth paying attention here.